AORTIC VALVE & CONDUIT SG SGAV00

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 02,06 report with the FDA on 2011-06-17 for AORTIC VALVE & CONDUIT SG SGAV00 manufactured by Cryolife, Inc..

Event Text Entries

[9476273] According to the report, a reoperation was required on a patient who received an aortic valve and conduit sg allograft eight years after implant. The surgeon stated that the allograft was very calcified and it was not an easy procedure. The surgeon expressed concern with the amount of calcification that was seen eight years post-operatively. A review of processing records indicates that the allograft met all processing specifications prior to release. The events described in the report are consistent with structural valve deterioration. Structural valve deterioration is a known potential complication of human heart valve transplantation and has been frequently reported in the literature. The precise cause of the reported event is unknown; however, calcification is a known mode of failure for human heart valve allografts. Data has shown that calcification is more likely in pediatric patients than in adults. There is no evidence to suggest that there was an intrinsic problem with the valve prior to implant. No further action is recommended at this time. This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event. Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
Patient Sequence No: 1, Text Type: N, H10


[22232503] According to the report, a reoperation was required on a patient who received an aortic valve and conduit sg allograft six years ago. The surgeon stated that the allograf was very calcified and it was not an easy procedure. The surgeon expressed concern with the amount of calcification that was seen six years post-operatively.
Patient Sequence No: 1, Text Type: D, B5


[22256931] .
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1063481-2011-00036
MDR Report Key2132930
Report Source02,06
Date Received2011-06-17
Date of Report2011-06-17
Date of Event2011-05-17
Date Mfgr Received2011-05-17
Date Added to Maude2011-06-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR. BRYAN BROSSEAU
Manufacturer Street1655 ROBERTS BLVD., NW
Manufacturer CityKENNESAW GA 30144
Manufacturer CountryUS
Manufacturer Postal30144
Manufacturer Phone7704193355
Manufacturer G1CRYOLIFE, INC.
Manufacturer Street1655 ROBERTS BLVD., NW
Manufacturer CityKENNESAW GA 30144
Manufacturer CountryUS
Manufacturer Postal Code30144
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameAORTIC VALVE & CONDUIT SG
Generic NameHEART ALLOGRAFT
Product CodeOHA
Date Received2011-06-17
Model NumberSGAV00
OperatorPHYSICIAN
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCRYOLIFE, INC.
Manufacturer Address1655 ROBERTS BLVD., NW KENNESAW GA 30144 US 30144


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2011-06-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.